In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma

Journal of Hematology & Oncology

Baksun Kim¹  Sabrina Khan¹  Junmin Wu¹  David T. Omstead¹  Jenna Sjoerdsma¹  Franklin Mejia¹  Tanyel Kiziltepe¹  Basar Bilgicer¹  Jaeho Shin¹  Laurie E. Littlepage² 

[1] Department of Chemical and Biomolecular Engineering, University of Notre Dame;Department of Chemistry and Biochemistry, University of Notre Dame;

关键词: Liposomes;    Peptide-targeted;    Multiple myeloma;    Drug-loaded;    Nanoparticle;    CD38;   

DOI  :  10.1186/s13045-020-00965-4

来源: DOAJ

【 摘 要 】

Abstract Background Drug-loaded nanoparticles have established their benefits in the fight against multiple myeloma; however, ligand-targeted nanomedicine has yet to successfully translate to the clinic due to insufficient efficacies reported in preclinical studies. Methods In this study, liposomal nanoparticles targeting multiple myeloma via CD38 or CD138 receptors are prepared from pre-synthesized, purified constituents to ensure increased consistency over standard synthetic methods. These nanoparticles are then tested both in vitro for uptake to cancer cells and in vivo for accumulation at the tumor site and uptake to tumor cells. Finally, drug-loaded nanoparticles are tested for long-term efficacy in a month-long in vivo study by tracking tumor size and mouse health. Results The targeted nanoparticles are first optimized in vitro and show increased uptake and cytotoxicity over nontargeted nanoparticles, with CD138-targeting showing superior enhancement over CD38-targeted nanoparticles. However, biodistribution and tumor suppression studies established CD38-targeted nanoparticles to have significantly increased in vivo tumor accumulation, tumor cell uptake, and tumor suppression over both nontargeted and CD138-targeted nanoparticles due to the latter’s poor selectivity. Conclusion These results both highlight a promising cancer treatment option in CD38-targeted nanoparticles and emphasize that targeting success in vitro does not necessarily translate to success in vivo.

【 授权许可】

Unknown